Medscape |
Probucol Reduces Events in Stroke Patients at Risk for ICH
Medscape The novel lipid-lowering antioxidant drug, probucol, reduced recurrent cardiovascular events in patients with ischemic stroke and a high risk for cerebral hemorrhage (ICH), in a new study. The PICASSO trial was presented at the 3rd European Stroke … |
21
MAY
MAY
0